Unternehmen BetterLife Pharma Inc. Other OTC
Aktien
A2P7XN
CA08772P2026
BETRF
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17.09.07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26.12.10 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05.02.15 |
David Melles
IRC | Investor Relations Contact | - | 29.09.21 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17.09.07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21.01.20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05.02.15 |
Ralph Pullen
BRD | Director/Board Member | 79 | 05.05.20 |
Steven Sangha
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 113 825 305 | 88 051 525 ( 77,36 %) | 0 | 77,36 % |
Unternehmenskontakt
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+604 221 0595
http://www.abetterlifepharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+7,77 % | 113 Mrd. | |
+10,39 % | 106 Mrd. | |
+0,41 % | 22,27 Mrd. | |
-11,99 % | 22,22 Mrd. | |
-5,99 % | 19,43 Mrd. | |
-37,36 % | 17,87 Mrd. | |
-5,22 % | 17,24 Mrd. | |
+6,52 % | 14,29 Mrd. | |
+36,22 % | 12,52 Mrd. |